BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34942480)

  • 1. Establishment of the induced pluripotent stem cell line (NCKDi005-A) from a male patient with Alport syndrome carrying a homozygous frameshift mutation in the COL4A4 gene.
    Wang G; Gao E; Wu H; Zhang L; Zhu Y; Zhang J; Liu Z
    Stem Cell Res; 2022 Jan; 58():102628. PubMed ID: 34942480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of the induced pluripotent stem cell line (NCKDi004-A) from a 17-year-old patient with Alport syndrome carrying a homozygous mutation in COL4A3 gene.
    Wu H; Wang G; Gao E; Zhang L; Zhu Y; Zhang J; Liu Z
    Stem Cell Res; 2021 Oct; 56():102557. PubMed ID: 34626894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digenic Alport Syndrome.
    Savige J; Renieri A; Ars E; Daga S; Pinto AM; Rothe H; Gale DP; Aksenova M; Cerkauskaite A; Bielska O; Lipska-Zietkiewicz B; Gibson JT
    Clin J Am Soc Nephrol; 2022 Nov; 17(11):1697-1706. PubMed ID: 35675912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autosomal-dominant Alport syndrome: natural history of a disease due to COL4A3 or COL4A4 gene.
    Pescucci C; Mari F; Longo I; Vogiatzi P; Caselli R; Scala E; Abaterusso C; Gusmano R; Seri M; Miglietti N; Bresin E; Renieri A
    Kidney Int; 2004 May; 65(5):1598-603. PubMed ID: 15086897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COL4A3/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome.
    Longo I; Porcedda P; Mari F; Giachino D; Meloni I; Deplano C; Brusco A; Bosio M; Massella L; Lavoratti G; Roccatello D; Frascá G; Mazzucco G; Muda AO; Conti M; Fasciolo F; Arrondel C; Heidet L; Renieri A; De Marchi M
    Kidney Int; 2002 Jun; 61(6):1947-56. PubMed ID: 12028435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autosomal recessive Alport syndrome: an in-depth clinical and molecular analysis of five families.
    Longo I; Scala E; Mari F; Caselli R; Pescucci C; Mencarelli MA; Speciale C; Giani M; Bresin E; Caringella DA; Borochowitz ZU; Siriwardena K; Winship I; Renieri A; Meloni I
    Nephrol Dial Transplant; 2006 Mar; 21(3):665-71. PubMed ID: 16338941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation and characterization of an integration-free iPSC line SDUBMSi006-A from a patient with Alport syndrome caused by COL4A3 gene mutations.
    Ma Y; Wang Z; Liu X; Sun W; Gong Y; Liu G; Sun G
    Stem Cell Res; 2021 Apr; 52():102237. PubMed ID: 33601099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autosomal recessive Alport's syndrome and benign familial hematuria are collagen type IV diseases.
    Tazón Vega B; Badenas C; Ars E; Lens X; Milà M; Darnell A; Torra R
    Am J Kidney Dis; 2003 Nov; 42(5):952-9. PubMed ID: 14582039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COL4A3/COL4A4 mutations and features in individuals with autosomal recessive Alport syndrome.
    Storey H; Savige J; Sivakumar V; Abbs S; Flinter FA
    J Am Soc Nephrol; 2013 Dec; 24(12):1945-54. PubMed ID: 24052634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome.
    Kamiyoshi N; Nozu K; Fu XJ; Morisada N; Nozu Y; Ye MJ; Imafuku A; Miura K; Yamamura T; Minamikawa S; Shono A; Ninchoji T; Morioka I; Nakanishi K; Yoshikawa N; Kaito H; Iijima K
    Clin J Am Soc Nephrol; 2016 Aug; 11(8):1441-1449. PubMed ID: 27281700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of digenic inheritance in Alport syndrome.
    Mencarelli MA; Heidet L; Storey H; van Geel M; Knebelmann B; Fallerini C; Miglietti N; Antonucci MF; Cetta F; Sayer JA; van den Wijngaard A; Yau S; Mari F; Bruttini M; Ariani F; Dahan K; Smeets B; Antignac C; Flinter F; Renieri A
    J Med Genet; 2015 Mar; 52(3):163-74. PubMed ID: 25575550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation analysis of COL4A3 and COL4A4 genes in a Chinese autosomal-dominant Alport syndrome family.
    Guo L; Li D; Dong S; Wan D; Yang B; Huang Y
    J Genet; 2017 Jun; 96(2):389-392. PubMed ID: 28674241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotype variability in a large Spanish family with Alport syndrome associated with novel mutations in COL4A3 gene.
    Cervera-Acedo C; Coloma A; Huarte-Loza E; Sierra-Carpio M; Domínguez-Garrido E
    BMC Nephrol; 2017 Oct; 18(1):325. PubMed ID: 29089023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COL4A4-related nephropathy caused by a novel mutation in a large consanguineous Saudi family.
    Ramzan K; Imtiaz F; Taibah K; Alnufiee S; Akhtar M; Al-Hazzaa SA; Al-Owain M
    Int J Pediatr Otorhinolaryngol; 2014 Mar; 78(3):427-32. PubMed ID: 24398087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autosomal dominant Alport syndrome: molecular analysis of the COL4A4 gene and clinical outcome.
    Marcocci E; Uliana V; Bruttini M; Artuso R; Silengo MC; Zerial M; Bergesio F; Amoroso A; Savoldi S; Pennesi M; Giachino D; Rombolà G; Fogazzi GB; Rosatelli C; Martinhago CD; Carmellini M; Mancini R; Di Costanzo G; Longo I; Renieri A; Mari F
    Nephrol Dial Transplant; 2009 May; 24(5):1464-71. PubMed ID: 19129241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of heterozygous pathogenic COL4A3 or COL4A4 variants on patients with X-linked Alport syndrome.
    Zhang Y; Ding J; Zhang H; Yao Y; Xiao H; Wang S; Wang F
    Mol Genet Genomic Med; 2019 May; 7(5):e647. PubMed ID: 30883042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sixteen novel mutations identified in COL4A3, COL4A4, and COL4A5 genes in Slovenian families with Alport syndrome and benign familial hematuria.
    Slajpah M; Gorinsek B; Berginc G; Vizjak A; Ferluga D; Hvala A; Meglic A; Jaksa I; Furlan P; Gregoric A; Kaplan-Pavlovcic S; Ravnik-Glavac M; Glavac D
    Kidney Int; 2007 Jun; 71(12):1287-95. PubMed ID: 17396119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autosomal dominant form of type IV collagen nephropathy exists among patients with hereditary nephritis difficult to diagnose clinicopathologically.
    Imafuku A; Nozu K; Sawa N; Hasegawa E; Hiramatsu R; Kawada M; Hoshino J; Tanaka K; Ishii Y; Takaichi K; Fujii T; Ohashi K; Iijima K; Ubara Y
    Nephrology (Carlton); 2018 Oct; 23(10):940-947. PubMed ID: 28704582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel mutations of COL4A3, COL4A4, and COL4A5 genes in Chinese patients with Alport Syndrome using next generation sequence technique.
    Zhao X; Chen C; Wei Y; Zhao G; Liu L; Wang C; Zhang J; Kong X
    Mol Genet Genomic Med; 2019 Jun; 7(6):e653. PubMed ID: 30968591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alport syndrome: deducing the mode of inheritance from the presence of haematuria in family members.
    Savige J
    Pediatr Nephrol; 2020 Jan; 35(1):59-66. PubMed ID: 30506145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.